Skip to content
Aperlena

TED - Tenders Electronic Daily (Publications Office of the EU) verified 1 week ago Prior information notice

Belgium - Vaccines for veterinary medicine - Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease

Upcoming Belgium Medical equipment & pharmaceuticals

Buyer European Commission, DG SANTE - Health and Food Safety

€3.2M estimated value · €3,200,000

Key facts

Published
  1. Published

TED - Tenders Electronic Daily (Publications Office of the EU) does not publish a closing date for this notice. See the official notice

View the official notice Watch this tender

We email you if the deadline moves or a correction is published. Free. Log in

Summary

Machine-generated summary

The European Commission is procuring a live attenuated homologous vaccine against Lumpy Skin Disease (LSD). The contract covers the purchase of an estimated maximum of 2,640,000 doses, consisting of an initial purchase of 528,000 doses plus up to four replenishments of the same size on request. The contractor must store an initial stock of 528,000 doses, readily available for delivery, and deliver maximum 2,640,000 doses in as many consignments as needed to destinations listed in the technical specifications. If the stock is depleted it must be replaced within 4 weeks. The contractor also stores any vaccines remaining at the end of the contract for the remainder of their shelf life and destroys and disposes of unused expired vaccine.

Description

REASON FOR PURCHASING The Commission has to maintain an estimated stock of at least 528.000 doses of live attenuated Lumpy Skin Disease (LSD) vaccine in storage in order to make it rapidly available in case it is needed. In addition, this stock of 528.000 doses of live attenuated vaccine should be replaced quickly, within 4 weeks, when depleted, in order to maintain the Union’s capability to respond to an emergency. PROCUREMENT DESCRIPTION The purpose of the contract is: • The purchase of an estimated maximum 2.640.000 doses of live attenuated homologous vaccine against LSD. This will be executed with one initial purchase of 528.000 and up to four (4) replenishments, of 528.000 doses each, upon request from the Commission. • The storage of an initial stock of 528.000 doses, readily available for delivery to any of the destinations listed in the technical specifications, that can be replaced, if depleted, partially or totally, up to 4 times until the end of the contract, upon request from the Commission. • The timely delivery of maximum 2.640.000 doses divided in as many consignments as needed to any of the destinations listed in the technical specifications • The storage of any vaccines in stock at the end of the contract for the remainder of their shelf life • The proper destruction and disposal of any unused vaccine at the end of its self life.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Report an error in this notice

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago

European Commission, DG SANTE - Health and Food Safety

Belgium

notices in the register
21
awards
4
awarded in total
€22.2M

Who wins its contracts

of its calls state an estimated value
63%

This buyer has no award history in this sector yet. Usual winners, Medical equipment & pharmaceuticals - Belgium

Company Wins Total awarded Last win
DUOMED BELGIUM 11 €2.2M Sep 2026
SIEMENS HEALTHCARE 10 €11.6M Sep 2026
GE HEALTHCARE 10 €6.8M Oct 2026
PHILIPS BELGIUM COMMERCIAL 9 €5.6M Aug 2026
Fresenius Kabi 8 €1.2M Oct 2026

Based on 522 awards with a linked company profile over the last 2 years.

Market context

open now in Medical equipment & pharmaceuticals
8,192
median open notice
€303,562

Who wins in this market

Many suppliers

Belgium · Medical equipment & pharmaceuticals

different companies won awards here
344
of the awards went to the three most frequent winners
6%
buyers awarded contracts here
141

Based on 522 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
2.5
of those lots received a single tender
23%
of the awards went to companies based in another country
13%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Change history

Every time an official source republished this notice with different content. We watch every source we index, including regional copies of the same notice.

  1. Estimated value
    not stated
    Now: €3,200,000

Follow this tender and we email you the moment it changes. Create account

Similar tenders

Open now

Awarded before

Never miss a tender like this

24 new notices in Medical equipment & pharmaceuticals in Belgium in the last 7 days. Get an email when new ones appear. Free.

Set up my alert

Or follow just its CPV code, Vaccines for veterinary medicine: an email when new tenders arrive under it, no account needed.

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language